论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
RUNX2 作为恶性肿瘤的有希望的治疗靶标
Authors Zhao W, Yang H, Chai J, Xing L
Received 15 January 2021
Accepted for publication 27 February 2021
Published 16 March 2021 Volume 2021:13 Pages 2539—2548
DOI https://doi.org/10.2147/CMAR.S302173
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
Abstract: The transcription factor runt-related protein 2 (RUNX2) has an important impact on the transformation of bone marrow mesenchymal stem cells to osteoblasts. Further studies have shown that RUNX2 plays a key role in the invasion and metastasis of cancers. RUNX2 is a “key” molecule in the regulatory network comprised of multiple signaling pathways upstream and its target downstream molecules. Due to the complex regulatory mechanisms of RUNX2, the specific mechanism underlying the occurrence, development and prognosis of malignant tumors has not been fully understood. Currently, RUNX2 as a promising therapeutic target for cancers has become a research hotspot. Herein, we reviewed the current literature on the modulatory functions and mechanisms of RUNX2 in the development of malignant tumors, aiming to explore its potential clinical application in the diagnosis, prognosis and treatment of tumors.
Keywords: RUNX2, malignant tumor;, research progress